TY - JOUR ID - 89139 TI - Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran JO - Asian Pacific Journal of Cancer Prevention JA - APJCP LA - en SN - 1513-7368 AU - Ebrahimi, Mahbobeh AU - Mehrzad, Valiollah AU - Moghaddas, Azadeh AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. AD - Department of Oncology/Hematology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Y1 - 2020 PY - 2020 VL - 21 IS - 6 SP - 1567 EP - 1572 KW - chemotherapy-induced nausea and vomiting KW - American Society of Clinical Oncology KW - guideline KW - Prophylaxis DO - 10.31557/APJCP.2020.21.6.1567 N2 - Introduction: Chemotherapy-induced nausea and vomiting (CINV) is one of the scariest chemotherapy-induced adverse effects. We evaluated the adherence to the 2017 American Society of Clinical Oncology (ASCO), the latest guideline recommendations, for the management of acute CINV at our institute. Methods: During a 6-months cross-sectional study on outpatient’s cancer patients, we collected data from the prescription documents during temporary hospitalization and compared the results with ASCO guideline recommendations. Results: The most prescribed prophylactic regimens for the management of CINV were combination of aprepitant, granisetron, and dexamethasone and metoclopramide (51.8%). Regarding prescription compatibility in our center with ASCO guideline recommnedations, selection of different regimens for prophylaxis of acute CINV in our institute was compliant in 0 %, 22%, 4%, and 40% of high, moderate, low, and minimal emetogenic potential of chemotherapy regimen groupss, respectively. Conclusion: Although our hospital is a referral and university-affiliated center, adherence to the ASCO guideline recommendations for prophylaxis of CINV was poor. UR - https://journal.waocp.org/article_89139.html L1 - https://journal.waocp.org/article_89139_a63589899400e25a3b34fa902f2ea593.pdf ER -